NESDEP detects pathogens in less than 90 minutes, and aims to provide significant cost savings whilst reducing the incidence of foodborne illnesses
Study demonstrates that the test can add prognostic information on overall survival
The Plasma-SeqSensei™ (PSS) NSCLC RUO (research use only) Kit detects mutations in circulating tumour DNA (ctDNA) from plasma in patients with non-small cell lung cancer.
White Raven installs Cytiva’s SA25 Aseptic Filling Workcell to reduce the risk of product contamination and handle multiple formats
In collaboration with the American Diabetes Association, the new guidelines are designed to improve patient care
Everything you need to know about our new exclusive Seal of Quality award, including the very first recipient
CellaVision announces the launch of DIFF-Line by CellaVision, a new workflow solution for low-volume hematology laboratories, at AACC
The VENTANA PD-L1 (SP263) Assay helps determine which non-small cell lung cancer patients may benefit from treatment with Tecentriq immunotherapy based on the results of the Phase III IMpower010 study
Ultra-high precision off-axis paraboloids are being used to maximize power density at the focus of Petawatt laser beamlines
This innovative solution will become available for both core and microbiology labs
Affordable Raman engine aims to provide OEM customers with unmatched detection limit
The partnership aims to co-market exosome technology as well as the joint development of new exosome based products
This new integration strengthens IDBS’ existing preclinical capabilities by seamlessly transferring data and enabling increased regulatory compliance
The acquisition aims to strengthen LGC’s existing product offering to the in vitro diagnostics sector
This launch represents an important step in Roche’s personalized healthcare strategy to fit treatments to patients who can benefit most from a specific medicine
